Israel Life Sciences Market Analysis
Single User PDF Format: US$ 800.00
Multi-User License: US$ 1,500.00
Hard Copy: US$ 900.00
CD-ROM: US$ 900.00
The field of life sciences has stipulated itself as one of the major businesses in Israel. The Israeli Life Sciences Industry boasts of over 700 companies with 40 companies being formed every year on an average. Extensive academic research, significant government support of early-stage research, rising demand for education and technological innovations are some of the factors that have been fueling growth in the Israeli Life Sciences Industry for the past few years.
As per our report “Israel Life Sciences Market Analysis”, Israeli companies have been joined by leading multinationals in making Israel a recognized force in the Life Sciences industry worldwide. Global giants, including J&J, Perrigo, GE Healthcare, Phillips Healthcare, together with local companies, such as Teva, itself now a multi-national company, Given Imaging, Insightec, Medinol, Disc-o-tech, Brainstorm and others have been continuously developing and marketing life changing medical breakthroughs and innovations in the country.
Our study indicates that, in 2010, medical devices formed the major part of the life sciences industry with a share of more than half of the life sciences company working in this segment. Israel’s strength in the segment curtails from inter-disciplinary competence, which brings together medicine, clinical proficiency, materials science, electronics, software capability, and engineering know-how.
The other major segment of businesses in life sciences includes biotech, medical IT & pharma. Our study indicates that, despite the fact that, Israeli biotechnology has a hold on the entire biotech field ranging from animal vaccines and diagnostics to plant tissue culture, bioreactors, seeds, diagnostics and biopesticides, its focus over the past few years has been mainly on biopharma, diagnostics and cell- and tissue-therapies.
Our report “Israel Life Sciences Market Analysis” highlights the Israeli Life Sciences Industry by segmenting it into medical devices, biotechnology, pharma, medical IT & Agro Biotech. Each of these segments have been thoroughly studied and analyzed in the report. Moreover, the report provides an overview of the investment scenario and recent M&As activity, which will help clients in identifying the future demand scenario.
The report studies the current market drivers and its effects on the incessant growth of the industry. The research contains exhaustive information about the market players, government initiatives, and macro-economic indicators that will help clients to draw up market strategies and assess opportunity areas in the Israeli Life Sciences Industry.
The report also includes a section of exports and analysis by therapeutics that presents a rough idea about the prospective business trends to facilitate clients comprehend, how the market will progress in coming years.
Multi-User License: US$ 1,500.00
Hard Copy: US$ 900.00
CD-ROM: US$ 900.00
The field of life sciences has stipulated itself as one of the major businesses in Israel. The Israeli Life Sciences Industry boasts of over 700 companies with 40 companies being formed every year on an average. Extensive academic research, significant government support of early-stage research, rising demand for education and technological innovations are some of the factors that have been fueling growth in the Israeli Life Sciences Industry for the past few years.
As per our report “Israel Life Sciences Market Analysis”, Israeli companies have been joined by leading multinationals in making Israel a recognized force in the Life Sciences industry worldwide. Global giants, including J&J, Perrigo, GE Healthcare, Phillips Healthcare, together with local companies, such as Teva, itself now a multi-national company, Given Imaging, Insightec, Medinol, Disc-o-tech, Brainstorm and others have been continuously developing and marketing life changing medical breakthroughs and innovations in the country.
Our study indicates that, in 2010, medical devices formed the major part of the life sciences industry with a share of more than half of the life sciences company working in this segment. Israel’s strength in the segment curtails from inter-disciplinary competence, which brings together medicine, clinical proficiency, materials science, electronics, software capability, and engineering know-how.
The other major segment of businesses in life sciences includes biotech, medical IT & pharma. Our study indicates that, despite the fact that, Israeli biotechnology has a hold on the entire biotech field ranging from animal vaccines and diagnostics to plant tissue culture, bioreactors, seeds, diagnostics and biopesticides, its focus over the past few years has been mainly on biopharma, diagnostics and cell- and tissue-therapies.
Our report “Israel Life Sciences Market Analysis” highlights the Israeli Life Sciences Industry by segmenting it into medical devices, biotechnology, pharma, medical IT & Agro Biotech. Each of these segments have been thoroughly studied and analyzed in the report. Moreover, the report provides an overview of the investment scenario and recent M&As activity, which will help clients in identifying the future demand scenario.
The report studies the current market drivers and its effects on the incessant growth of the industry. The research contains exhaustive information about the market players, government initiatives, and macro-economic indicators that will help clients to draw up market strategies and assess opportunity areas in the Israeli Life Sciences Industry.
The report also includes a section of exports and analysis by therapeutics that presents a rough idea about the prospective business trends to facilitate clients comprehend, how the market will progress in coming years.
1. ANALYST VIEW
2. RESEARCH METHODOLOGY
3. ISRAEL: ECONOMIC INDICATORS & COMPETITIVE EDGE
4. MARKET DRIVERS
4.1 Excellent Academic Environment
4.2 Co-operation among Academia, Research & Business
4.3 Global Recognition through Innovations
4.4 Customized Research Infrastructure
4.5 Government Initiatives
5. ISRAEL LIFE SCIENCES INDUSTRY: AN OVERVIEW
5.1 Market Size and Growth
5.2 Market Sectors
5.2.1 Medical Devices
5.2.2 Biotechnology
5.2.3 Pharmaceutical
5.2.4 AgroBiotech
5.2.5 Medical IT
5.3 Segmentation by Therapeutics
5.4 Exports
6. INVESTMENTS SCENARIO
7. RECENT M&A ACTIVITY
8. COMPETITIVE LANDSCAPE
8.1 Perrigo Pharmaceuticals Ltd.
8.2 Roche
8.3 Merck & Co.
8.4 Sun Pharmaceutical
8.5 GE Healthcare
8.6 Teva Pharmaceutical Industries Limited
2. RESEARCH METHODOLOGY
3. ISRAEL: ECONOMIC INDICATORS & COMPETITIVE EDGE
4. MARKET DRIVERS
4.1 Excellent Academic Environment
4.2 Co-operation among Academia, Research & Business
4.3 Global Recognition through Innovations
4.4 Customized Research Infrastructure
4.5 Government Initiatives
5. ISRAEL LIFE SCIENCES INDUSTRY: AN OVERVIEW
5.1 Market Size and Growth
5.2 Market Sectors
5.2.1 Medical Devices
5.2.2 Biotechnology
5.2.3 Pharmaceutical
5.2.4 AgroBiotech
5.2.5 Medical IT
5.3 Segmentation by Therapeutics
5.4 Exports
6. INVESTMENTS SCENARIO
7. RECENT M&A ACTIVITY
8. COMPETITIVE LANDSCAPE
8.1 Perrigo Pharmaceuticals Ltd.
8.2 Roche
8.3 Merck & Co.
8.4 Sun Pharmaceutical
8.5 GE Healthcare
8.6 Teva Pharmaceutical Industries Limited
LIST OF FIGURES:
Figure 4-1: Number of Ph.D. Graduates (2003-04 & 2008-09)
Figure 4-2: Global - Number of Scientific Publications & Citations of Leading Countries (per Million Inhabitants)
Figure 4-3: Chief Scientist Grants by Technological Sectors (%), 2009
Figure 4-4: Chief Scientist Grants in Life Sciences Industry (Million US$), 2007-2010
Figure 4-5: Chief Scientist Grants in Life Sciences Industry by Sector (%), 2010
Figure 4-6: Incubated Companies by Sector (%)
Figure 5-1: Number of Companies Founded in Life Sciences Industry (2005-2009)
Figure 5-2: Life Sciences Companies by Sector (%), 2010
Figure 5-3: Medical Devices Companies by Sub-Sector (%), 2010
Figure 5-4: Clinical Trials of New Molecules in Biopharma by Phase (%), 2010
Figure 5-5: Pharmaceutical Companies by Sub-Sector (%), 2010
Figure 5-6: Life Sciences Companies by Therapeutics (%), 2010
Figure 5-7: Life Sciences Export (Billion US$), 2008 & 2009
Figure 5-8: Life Sciences Export by Countries (%), Q1 2010
LIST OF TABLE:
Table 3-1: Major Economic Indicators (2007-2010)
Table 3-2: Israel’s Competitiveness Ranking (2010)
Table 4-1: Recipients of Academic Degrees in Life Sciences (Number), 2007-08
Table 4-2: List of Blockbuster Launched Products by Company
Table 5-1: Biotech Companies by Sub-Sector (%), 2010
Table 6-1: Life Sciences Industry Financing by Source (Million US$), 2010
Table 7-1: Mergers & Acquisitions in Life Sciences Industry (Million US$), 2008 to 2011
Figure 4-1: Number of Ph.D. Graduates (2003-04 & 2008-09)
Figure 4-2: Global - Number of Scientific Publications & Citations of Leading Countries (per Million Inhabitants)
Figure 4-3: Chief Scientist Grants by Technological Sectors (%), 2009
Figure 4-4: Chief Scientist Grants in Life Sciences Industry (Million US$), 2007-2010
Figure 4-5: Chief Scientist Grants in Life Sciences Industry by Sector (%), 2010
Figure 4-6: Incubated Companies by Sector (%)
Figure 5-1: Number of Companies Founded in Life Sciences Industry (2005-2009)
Figure 5-2: Life Sciences Companies by Sector (%), 2010
Figure 5-3: Medical Devices Companies by Sub-Sector (%), 2010
Figure 5-4: Clinical Trials of New Molecules in Biopharma by Phase (%), 2010
Figure 5-5: Pharmaceutical Companies by Sub-Sector (%), 2010
Figure 5-6: Life Sciences Companies by Therapeutics (%), 2010
Figure 5-7: Life Sciences Export (Billion US$), 2008 & 2009
Figure 5-8: Life Sciences Export by Countries (%), Q1 2010
LIST OF TABLE:
Table 3-1: Major Economic Indicators (2007-2010)
Table 3-2: Israel’s Competitiveness Ranking (2010)
Table 4-1: Recipients of Academic Degrees in Life Sciences (Number), 2007-08
Table 4-2: List of Blockbuster Launched Products by Company
Table 5-1: Biotech Companies by Sub-Sector (%), 2010
Table 6-1: Life Sciences Industry Financing by Source (Million US$), 2010
Table 7-1: Mergers & Acquisitions in Life Sciences Industry (Million US$), 2008 to 2011
